The molecular genetics of Marfan syndrome and related disorders

Peter N. Robinson, E. Arteaga-Solis, C. Baldock, G. Collod-Béroud, P. Booms, A. De Paepe, H. C. Dietz, G. Guo, P. A. Handford, D. P. Judge, C. M. Kielty, B. Loeys, D. M. Milewicz, A. Ney, F. Ramirez, D. P. Reinhardt, K. Tiedemann, P. Whiteman, M. Godfrey

    Research output: Contribution to journalArticlepeer-review


    Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated individuals with MFS is acute aortic dissection, which often follows a period of progressive dilatation of the ascending aorta. Recent research on the molecular physiology of fibrillin and the pathophysiology of MFS and related disorders has changed our understanding of this disorder by demonstrating changes in growth factor signalling and in matrix-cell interactions. The purpose of this review is to provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils. Mutations in FBN1 and other genes found in MFS and related disorders will be discussed, and novel concepts concerning the complex and multiple mechanisms of the pathogenesis of MFS will be explained.
    Original languageEnglish
    Pages (from-to)769-787
    Number of pages18
    JournalJournal of Medical Genetics
    Issue number10
    Publication statusPublished - Oct 2006


    Dive into the research topics of 'The molecular genetics of Marfan syndrome and related disorders'. Together they form a unique fingerprint.

    Cite this